نتایج جستجو برای: release microsphere

تعداد نتایج: 217328  

2013
Murugesh Shivashankar Badal Kumar Mandal

Purpose: To develop a chitosan microsphere carrier system of bupivacaine for buccal administration. Methods: Chitosan microspheres loaded with bupivacaine were prepared by emulsification technique based on glutaraldehyde cross-linking and drug-loaded chitosan microsphere were coated with polyglycolic acid (PGA) film The formulated microspheres were characterized by x-ray diffraction (XRD), diff...

Journal: :Frontiers in endocrinology 2015
Chunhui Jiang Liangju Kuang Madeline P. Merkel Feng Yue Mario Alberto Cano-Vega Naagarajan Narayanan Shihuan Kuang Meng Deng

Brown and beige adipocytes are potent therapeutic agents to increase energy expenditure and reduce risks of obesity and its affiliated metabolic symptoms. One strategy to increase beige adipocyte content is through inhibition of the evolutionarily conserved Notch signaling pathway. However, systemic delivery of Notch inhibitors is associated with off-target effects and multiple dosages of appli...

Journal: :Journal of controlled release : official journal of the Controlled Release Society 2003
Jae-Hyung Jang Lonnie D Shea

The inductive approach to tissue engineering combines three-dimensional porous scaffolds with drug delivery to direct the action of progenitor cells into a functional tissue. We present an approach to fabricate scaffolds capable of controlled, sustained delivery by the assembly and subsequent fusion of drug-loaded microspheres using a gas foaming/particulate leaching process. DNA-loaded microsp...

2012
M. J. Barea M. J. Jenkins Y. S. Lee P. Johnson R. H. Bridson

A novel liposome-in-microsphere (LIM) formulation has been created comprising drug-loaded liposomes within pH responsive Eudragit S100 microspheres. The liposomes contained the model drug 5-ASA and were coated with chitosan in order to protect them during encapsulation within the microspheres and to improve site-specific release characteristics. In vitro drug release studies showed that LIMs pr...

Alireza Mahboubian Fatemeh Atyabi, Rassoul Dinarvand, Seyyed Kazem Hashemein Shadi Moghadam

Triptoreline is a potent agonist of luteinizing hormone-releasing hormone, currently used in the treatment of prostatic cancer where therapy may be required over months or years. Frequent injection of drug decreases patients’ compliance. The present study describes the formulation of a sustained release microparticulate drug delivery system containing triptoreline acetate, using poly (D,L lacti...

Journal: :jundishapur journal of natural pharmaceutical products 0
mitra jelvehgari drug applied research center, tabriz university of medical sciences, tabriz, ir iran; faculty of pharmacy, tabriz university of medical sciences, tabriz, ir iran; drug applied research center, tabriz university of medical sciences, tabriz, ir iran. tel: +98-4113392617, fax: +98-4113344798 leila barghi faculty of pharmacy, tabriz university of medical sciences, tabriz, ir iran farhad barghi student research committee, tabriz university of medical sciences, tabriz, ir iran

conclusions: the results of the present study indicated that oral preparation of cm with an acceptable taste is feasible. background: chlorpheniramine maleate (cm) is widely used as an antihistaminic drug but it is very bitter and as yet no mouth dissolving/disintegrating taste-masked preparation that might be useful for pediatric and geriatric patients is available in the market. objectives: t...

Alireza Mahboubian Fatemeh Atyabi, Rassoul Dinarvand, Seyyed Kazem Hashemein Shadi Moghadam

Triptoreline is a potent agonist of luteinizing hormone-releasing hormone, currently used in the treatment of prostatic cancer where therapy may be required over months or years. Frequent injection of drug decreases patients’ compliance. The present study describes the formulation of a sustained release microparticulate drug delivery system containing triptoreline acetate, using poly (D,L lacti...

Journal: :Biotechnology and bioengineering 2015
Kasra Tajdaran Molly S Shoichet Tessa Gordon Gregory H Borschel

Despite substantial improvement in microsurgical techniques for nerve repair, recovery after peripheral nerve injury is usually incomplete. FK506, an FDA approved immunosuppressant, improves functional recovery and reinnervation following peripheral nerve injury in animal models. However, systemically delivered FK506 causes undesirable global immunosuppression. We have, therefore, engineered a ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید